Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome
- PMID: 12163790
- DOI: 10.1097/00003246-200208000-00015
Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome
Abstract
Objective: To determine prevalence, risk factors, and outcome of thrombocytopenia in medical intensive care patients.
Design: Prospective observational study.
Setting: The 12-bed medical intensive care unit of a university hospital.
Patients: All consecutively admitted patients with normal platelet count at admission and an intensive care unit stay of >48 hrs during a 13-month period (n = 145).
Measurements and main results: The prevalence of intensive care unit-acquired thrombocytopenia (platelet count, <150.0/nL) was 64 of 145 patients (44%). Intensive care unit mortality was 31% in thrombocytopenic patients and 16% in nonthrombocytopenic patients (p =.03). Mortality was higher in patients with a nadir platelet count of <100.0/nL (p <.001) and in patients with a drop in platelet count of >/=30% (p <.001). In nonsurvivors, the decrease in platelet count was greater (p <.001), the nadir platelet count lower (p <.001), and the duration of thrombocytopenia longer (p =.008) than in survivors. A logistic regression analysis identified septic shock (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.40-9.52), a higher Acute Physiology and Chronic Health Evaluation II Score at admission (OR, 1.06 for 1 point; 95% CI, 1.01-1.12), and a drop in platelet count exceeding 30% (OR, 3.73; 95% CI, 1.24-11.21), but not thrombocytopenia, as independent risk factors for intensive care unit death. Correction of thrombocytopenia was associated with reduced mortality (OR, 0.002; 95% CI, 0-0.08). Major bleeding prevalence and transfusion requirements were significantly higher with thrombocytopenia. Nadir platelet count was the only independent risk factor for bleeding (OR, 4.1 for every 100.0/nL; 95% CI, 1.9-8.8). Independently associated with thrombocytopenia were disseminated intravascular coagulation (OR, 14.94; 95% CI, 3.92-57.00), cardiopulmonary resuscitation as an admission category (OR, 5.17; 95% CI, 1.42-18.85), and a higher Sequential Organ Failure Assessment score (OR, 1.20 for a 1 point change; 95% CI, 1.02-1.40).
Conclusions: Thrombocytopenia is common in medical intensive care unit patients. Thrombocytopenic patients have a higher prevalence of bleeding and greater transfusion requirements. A drop in platelet counts of > or = 30%, but not thrombocytopenia per se, is independently associated with intensive care unit death. Serial measurements of platelet counts are important and readily available markers for monitoring the patient's condition. Any drop in platelet count requires urgent clarification. Disseminated intravascular coagulation, signs of organ failure at admission, and cardiopulmonary resuscitation are predictors of intensive care unit-acquired thrombocytopenia.
Comment in
-
Thrombocytopenia and intensive care unit outcome: a sticky issue.Crit Care Med. 2002 Aug;30(8):1917-8. doi: 10.1097/00003246-200208000-00048. Crit Care Med. 2002. PMID: 12163823 No abstract available.
Similar articles
-
Thrombocytopenia and prognosis in intensive care.Crit Care Med. 2000 Jun;28(6):1871-6. doi: 10.1097/00003246-200006000-00031. Crit Care Med. 2000. PMID: 10890635
-
Time course of platelet counts in critically ill patients.Crit Care Med. 2002 Apr;30(4):753-6. doi: 10.1097/00003246-200204000-00005. Crit Care Med. 2002. PMID: 11940740
-
Platelet counts and outcome in the pediatric intensive care unit.Indian J Crit Care Med. 2008 Jul;12(3):102-8. doi: 10.4103/0972-5229.43678. Indian J Crit Care Med. 2008. PMID: 19742257 Free PMC article.
-
[Thrombocytopenia in the intensive care unit : Diagnosis, differential diagnosis, and treatment].Med Klin Intensivmed Notfmed. 2016 Jun;111(5):425-33. doi: 10.1007/s00063-016-0174-8. Epub 2016 Jun 2. Med Klin Intensivmed Notfmed. 2016. PMID: 27255225 Free PMC article. Review. German.
-
Thrombocytopenia in the intensive care unit-diagnostic approach and management.Semin Hematol. 2013 Jul;50(3):239-50. doi: 10.1053/j.seminhematol.2013.06.008. Semin Hematol. 2013. PMID: 23953341 Review.
Cited by
-
Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.Trials. 2018 Feb 20;19(1):127. doi: 10.1186/s13063-018-2480-3. Trials. 2018. PMID: 29463280 Free PMC article.
-
Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.Semin Immunopathol. 2012 Jan;34(1):167-79. doi: 10.1007/s00281-011-0283-7. Epub 2011 Jul 30. Semin Immunopathol. 2012. PMID: 21805225 Free PMC article. Review.
-
Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies.Ann Intensive Care. 2017 Dec 11;7(1):119. doi: 10.1186/s13613-017-0341-y. Ann Intensive Care. 2017. PMID: 29230562 Free PMC article.
-
Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?Ann Intensive Care. 2017 Dec 1;7(1):115. doi: 10.1186/s13613-017-0337-7. Ann Intensive Care. 2017. PMID: 29192366 Free PMC article. Review.
-
Platelet Distribution Width to Platelet Count Ratio as an Index of Severity of Illness.Indian J Pediatr. 2018 Jan;85(1):10-14. doi: 10.1007/s12098-017-2432-z. Epub 2017 Aug 26. Indian J Pediatr. 2018. PMID: 28842812
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources